| scholarly article | Q13442814 |
| P2093 | author name string | J Wu | |
| J H Phillips | |||
| L L Lanier | |||
| B Corliss | |||
| P2860 | cites work | DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells | Q24295237 |
| Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C | Q24309230 | ||
| Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C | Q24309260 | ||
| Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways | Q24310455 | ||
| The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions | Q24310543 | ||
| Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells | Q24314176 | ||
| Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily | Q24314332 | ||
| Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells | Q24315619 | ||
| Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains | Q73101506 | ||
| Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains | Q24317666 | ||
| Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor | Q24318464 | ||
| NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor | Q24670229 | ||
| NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules | Q24679688 | ||
| A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains | Q27913878 | ||
| The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9 | Q28239867 | ||
| The human natural killer gene complex is located on chromosome 12p12-p13 | Q28243367 | ||
| Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes | Q28256177 | ||
| Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors | Q28259065 | ||
| Human diversity in killer cell inhibitory receptor genes | Q28259075 | ||
| Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases | Q28263470 | ||
| HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C | Q28263511 | ||
| CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes | Q28287599 | ||
| Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer | Q28287988 | ||
| Biology of natural killer cells | Q29619728 | ||
| Role of potentially charged transmembrane residues in targeting proteins for retention and degradation within the endoplasmic reticulum | Q35930805 | ||
| HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A | Q36065870 | ||
| The lysine residue in the membrane-spanning domain of the beta chain is necessary for cell surface expression of the T cell antigen receptor | Q36355748 | ||
| The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity | Q36377146 | ||
| Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis | Q36400442 | ||
| A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells | Q36770801 | ||
| Cloning and physical mapping of the HLA class I region spanning the HLA-E-to-HLA-F interval by using yeast artificial chromosomes | Q36915126 | ||
| Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule | Q37492925 | ||
| The role of natural killer cells in host-parasite interactions | Q40540042 | ||
| Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs. | Q41116803 | ||
| Human natural killer cell inhibitory receptors bind to HLA class I molecules | Q41234451 | ||
| Colocalized transmembrane determinants for ER degradation and subunit assembly explain the intracellular fate of TCR chains | Q41715231 | ||
| Follow the leader: NK cell receptors for classical and nonclassical MHC class I. | Q41732625 | ||
| Role of CD3 gamma in T cell receptor assembly. | Q42015248 | ||
| Regulation and function of the CD3gamma DxxxLL motif: a binding site for adaptor protein-1 and adaptor protein-2 in vitro. | Q42831149 | ||
| Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones | Q44398170 | ||
| Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. | Q45984838 | ||
| Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells | Q46754099 | ||
| NK cell receptors | Q46858751 | ||
| Molecular characterization of a gene in the rat homologous to human CD94. | Q48046347 | ||
| Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors | Q48052628 | ||
| Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex | Q57200936 | ||
| The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules | Q57200941 | ||
| Membrane protein association by potential intrarnembrane charge pairs | Q59054338 | ||
| The activating form of CD94 receptor complex: CD94 covalently associated with the Kp39 protein that represents the product of the NKG2-C gene | Q61953875 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 693-701 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Association of DAP12 with activating CD94/NKG2C NK cell receptors | |
| P478 | volume | 8 |
| Q24291798 | A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells |
| Q37634635 | A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART. |
| Q38568874 | A bird's eye view of NK cell receptor interactions with their MHC class I ligands |
| Q24676716 | A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells |
| Q28211474 | A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex |
| Q36371883 | A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition |
| Q37816649 | A view into the blind spot: solution NMR provides new insights into signal transduction across the lipid bilayer. |
| Q36707206 | Activating and inhibitory functions of DAP12. |
| Q37766751 | Activating and inhibitory receptors of natural killer cells |
| Q80374068 | Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion |
| Q28588971 | Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor |
| Q37479319 | Activation of natural killer cells by heat shock protein 70. 2002. |
| Q38095771 | Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction |
| Q60212988 | Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells |
| Q30918649 | Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes |
| Q47934441 | Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets |
| Q53563360 | Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease. |
| Q34465877 | Balancing natural killer cell activation through paired receptors |
| Q26752544 | Biochemical and Functional Insights into the Integrated Regulation of Innate Immune Cell Responses by Teleost Leukocyte Immune-Type Receptors |
| Q34651546 | Biology of natural killer cells in cancer and infection |
| Q92299151 | Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells |
| Q64970629 | CAR-Expressing Natural Killer Cells for Cancer Retargeting. |
| Q33869275 | CD1, tuberculosis, and the evolution of major histocompatibility complex molecules |
| Q24630430 | CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression |
| Q41467332 | CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. |
| Q54519853 | CD5-low expression lymphocytes in canine peripheral blood show characteristics of natural killer cells. |
| Q35015677 | CD8⁺ T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung |
| Q39807909 | Canine CD8 T cells showing NK cytotoxic activity express mRNAs for NK cell-associated surface molecules |
| Q35848101 | Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy. |
| Q38685785 | Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV. |
| Q92845938 | Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming |
| Q24649116 | Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling |
| Q37907929 | Clinical significance of the HLA-E and CD94/NKG2 interaction |
| Q41828664 | Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors. |
| Q30657557 | Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family |
| Q40850965 | Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. |
| Q36981178 | Common themes in the assembly and architecture of activating immune receptors |
| Q74419349 | Complex expression of natural killer receptor genes in single natural killer cells |
| Q53572572 | Complexity in the cattle CD94/NKG2 gene families. |
| Q93165007 | Computational Approach to Identifying Universal Macrophage Biomarkers |
| Q90664677 | Conserved and variable natural killer cell receptors: diverse approaches to viral infections |
| Q60146888 | Conserved lipid and peptide presentation functions of nonclassical class I molecules |
| Q36304347 | Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors. |
| Q36874773 | Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans. |
| Q27630065 | Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A |
| Q40698451 | Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells. |
| Q77398610 | Cytotoxic lymphocyte recognition of HLA-E: utilizing a nonclassical window to peer into classical MHC |
| Q24675903 | DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells |
| Q37361459 | DAP10- and DAP12-associated receptors in innate immunity |
| Q34005730 | DAP12 and KAP10 (DAP10)-novel transmembrane adapter proteins of the CD3zeta family |
| Q50292167 | DAP12 interacts with NKG2C |
| Q46091534 | DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming |
| Q28610866 | DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase |
| Q33686435 | DAP12: a key accessory protein for relaying signals by natural killer cell receptors |
| Q36557562 | Detecting the unusual: natural killer cells |
| Q33769518 | Development and function of CD94-deficient natural killer cells |
| Q41845995 | Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease |
| Q40709378 | Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones |
| Q44143263 | Disordered expression of inhibitory receptors on the NK1-type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites |
| Q36652172 | Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse |
| Q28488034 | Dissection of agonistic and blocking effects of CD200 receptor antibodies |
| Q47551334 | Diversification of human NK cells: Lessons from deep profiling |
| Q36176106 | Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts. |
| Q99712060 | Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection |
| Q33829864 | Early signaling via inhibitory and activating NK receptors |
| Q37440077 | Endocytosis and intracellular trafficking of human natural killer cell receptors |
| Q90212487 | Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma |
| Q46737044 | Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. |
| Q34401884 | Evolution of effectors and receptors of innate immunity |
| Q35202828 | Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection |
| Q50934124 | Expression and Purification of a Functional Porcine Soluble Triggering Receptor Expressed on Myeloid Cells 1. |
| Q33653648 | Function of the CD3 subunits of the pre-TCR and TCR complexes during T cell development. |
| Q53079635 | Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus. |
| Q40735567 | Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis. |
| Q24291649 | G6b, a novel immunoglobulin superfamily member encoded in the human major histocompatibility complex, interacts with SHP-1 and SHP-2 |
| Q40101568 | GSK 3 inhibition drives maturation of NK cells and enhances their antitumor activity |
| Q28570776 | Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12 |
| Q47260453 | Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases |
| Q34376850 | Genetic and functional relationships between MHC and NK receptor genes |
| Q58606323 | HLA-E Peptide Repertoire and Dimorphism-Centerpieces in the Adaptive NK Cell Puzzle? |
| Q35562516 | Hair regrowth in alopecia areata patients following Stem Cell Educator therapy |
| Q28081448 | Harnessing adaptive natural killer cells in cancer immunotherapy |
| Q36963143 | Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance |
| Q36732703 | Human CD8+ intraepithelial lymphocytes: a unique model to study the regulation of effector cytotoxic T lymphocytes in tissue |
| Q38984012 | Human NKG2E is expressed and forms an intracytoplasmic complex with CD94 and DAP12. |
| Q90439411 | Human Natural Killer Receptors, Co-Receptors, and Their Ligands |
| Q36371763 | Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential |
| Q37374455 | Human embryo immune escape mechanisms rediscovered by the tumor. |
| Q34277965 | Human natural killer cell activating receptors. |
| Q34552143 | Human natural killer cell receptors and signal transduction |
| Q36320503 | Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation |
| Q24671834 | Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells |
| Q36915881 | Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets |
| Q61248562 | Immune evasion by TGFβ-induced miR-183 repression of MICA/B expression in human lung tumor cells |
| Q24651329 | Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice |
| Q59356151 | Impact of the Variable Killer Ig-Like Receptor-Human Leukocyte Antigen Interactions on Natural Killer Cell Cytotoxicity Toward Foreign CD4 T Cells |
| Q37170876 | Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells. |
| Q57200902 | Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children |
| Q33653653 | Inhibitory pathways triggered by ITIM-containing receptors. |
| Q73256383 | Interaction of the NK cell inhibitory receptor Ly49A with H-2Dd: identification of a site distinct from the TCR site |
| Q34537157 | Interactions between natural killer cells, cortisol and prolactin in malaria during pregnancy |
| Q24598715 | Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention |
| Q38015720 | Intraepithelial lymphocytes in celiac disease immunopathology |
| Q36959049 | KLRE/I1 and KLRE/I2: a novel pair of heterodimeric receptors that inversely regulate NK cell cytotoxicity |
| Q33908939 | Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. |
| Q37273319 | Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection |
| Q34082781 | MIC genes: from genetics to biology |
| Q34494545 | Mammalian non-classical major histocompatibility complex I and its receptors: Important contexts of gene, evolution, and immunity |
| Q28235543 | Membrane proteins with immunoglobulin-like domains--a master superfamily of interaction molecules |
| Q64259394 | Memory NK Cell Features Exploitable in Anticancer Immunotherapy |
| Q38808390 | Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells |
| Q37372820 | Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. |
| Q90083163 | Mirc11 Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells |
| Q37143135 | Mistaken notions about natural killer cells |
| Q40843782 | Mitogen-activated protein kinase activity is involved in effector functions triggered by the CD94/NKG2-C NK receptor specific for HLA-E. |
| Q35749202 | Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig molecules |
| Q33829853 | Molecular analyses of the interactions between human NK receptors and their HLA ligands |
| Q28142753 | Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4 |
| Q28509229 | Molecular cloning of KLRI1 and KLRI2, a novel pair of lectin-like natural killer-cell receptors with opposing signalling motifs |
| Q34078574 | Molecular dynamic simulation of the self-assembly of DAP12-NKG2C activating immunoreceptor complex |
| Q24646967 | Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b) |
| Q24611595 | Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype |
| Q22003745 | Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells |
| Q33846328 | NK and NK/T cells in human senescence |
| Q40803957 | NK and T cells constitute two major, functionally distinct intestinal epithelial lymphocyte subsets in the chicken |
| Q33829849 | NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals |
| Q33547794 | NK cells and apoptosis. |
| Q35539280 | NK cells and immune "memory" |
| Q38568884 | NK cells: tuned by peptide? |
| Q51033778 | NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease. |
| Q42270076 | NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus |
| Q35925878 | NKG2D and Related Immunoreceptors |
| Q52653107 | NKG2H-Expressing T Cells Negatively Regulate Immune Responses. |
| Q34167778 | NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human |
| Q35720396 | Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects |
| Q46722989 | Natural Killer Cell Interactions with Classical and Non-Classical Human Leukocyte Antigen Class I in HIV-1 Infection |
| Q91939030 | Natural Killer Cell Receptor Genes in Camels: Another Mammalian Model |
| Q35035726 | Natural killer cell activation receptors in innate immunity to infection |
| Q34510646 | Natural killer cell memory in infection, inflammation and cancer |
| Q56966491 | Natural killer cell specificity for viral infections |
| Q33922176 | Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors. |
| Q35622883 | Natural killer cells and cancer |
| Q34148233 | Natural killer cells and their receptors |
| Q33703408 | Natural killer cells in healthy aging |
| Q58092158 | Natural killer cells in lung transplantation |
| Q34117069 | On guard--activating NK cell receptors |
| Q30439982 | PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling |
| Q33829844 | Paired inhibitory and triggering NK cell receptors for HLA class I molecules. |
| Q38986444 | Paired opposing leukocyte receptors recognizing rapidly evolving ligands are subject to homogenization of their ligand binding domains |
| Q37774818 | Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes. |
| Q27481031 | Phenotypic and Functional Changes of Cytotoxic CD56pos Natural T Cells Determine Outcome of Acute Hepatitis C Virus Infection |
| Q40603140 | Platelet-Derived Ectosomes Reduce NK Cell Function. |
| Q28588924 | Positive regulation of phagocytosis by SIRPbeta and its signaling mechanism in macrophages |
| Q28265298 | Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity |
| Q36375639 | Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells |
| Q30430960 | Regulation of NK cell repertoire and function in the liver |
| Q33898944 | Regulation of T cell function by NK cell receptors for classical MHC class I molecules. |
| Q36238119 | Reprogramming of CTLs into natural killer-like cells in celiac disease |
| Q46734905 | Restricted expression of C-type lectin-like natural killer receptors by CD8 T cells in the murine small intestine |
| Q34440428 | SIRPbeta1 is expressed as a disulfide-linked homodimer in leukocytes and positively regulates neutrophil transepithelial migration |
| Q36370648 | Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells |
| Q57200924 | Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease |
| Q28573024 | Self-MHC class Ia (RT1-A(n)) protects cells co-expressing the activatory allogeneic MHC class Ib molecule (RT1-E(u)) from NK lysis |
| Q92547209 | Simian Immunodeficiency Virus Infection Modulates CD94+ (KLRD1+) NK Cells in Rhesus Macaques |
| Q42282045 | Spotlight on NKG2C and the human NK-cell response to CMV infection |
| Q28209910 | Src-mediated RGS16 tyrosine phosphorylation promotes RGS16 stability |
| Q36317668 | Structural insights into activation of antiviral NK cell responses |
| Q28610389 | Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells |
| Q27639773 | Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors |
| Q39217707 | T Cells in Celiac Disease. |
| Q36087376 | TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release |
| Q24676756 | Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells |
| Q36685564 | The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. |
| Q34424423 | The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells |
| Q34103308 | The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function |
| Q41684097 | The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy. |
| Q41843732 | The Natural Selection of Herpesviruses and Virus-Specific NK Cell Receptors |
| Q36742734 | The association of polar residues in the DAP12 homodimer: TOXCAT and molecular dynamics simulation studies |
| Q34402067 | The biology of natural killer cells in cancer, infection, and pregnancy |
| Q96683799 | The cancer-natural killer cell immunity cycle |
| Q35640941 | The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells. |
| Q28566558 | The lectin-like receptor KLRE1 inhibits natural killer cell cytotoxicity |
| Q37206656 | The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing |
| Q35838656 | The role of CD94/NKG2 in innate and adaptive immunity |
| Q26753146 | The role of NK cells in HIV-1 protection: autologous, allogeneic or both? |
| Q24301707 | The structural basis for intramembrane assembly of an activating immunoreceptor complex |
| Q40874638 | The tyrosine kinase PYK-2/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific target cell recognition and killing |
| Q35666017 | Transmembrane Complexes of DAP12 Crystallized in Lipid Membranes Provide Insights into Control of Oligomerization in Immunoreceptor Assembly. |
| Q33894477 | Turning on natural killer cells |
| Q64228645 | Two to Tango: Co-evolution of Hominid Natural Killer Cell Receptors and MHC |
| Q33594882 | Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice |
| Q80892681 | Variable NKG2 expression in the peripheral blood lymphocytes of rhesus monkeys |
| Q48163749 | Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease. |
| Q81353635 | Variation in the ligand binding domains of the CD94/NKG2 family of receptors in the squirrel monkey |
| Q35035721 | Virus-driven evolution of natural killer cell receptors. |
| Q47891759 | Vps35-dependent recycling of Trem2 regulates microglial function |
Search more.